BiotechTube

rotavirus vaccine, live, oral, pentavalent + Placebo

Phase 3Completed
1 views this week 0 watching⚡ Active
Interest: 40/100
40
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Rotavirus Infections

Conditions

Rotavirus Infections

Trial Timeline

May 1, 2003 → Aug 1, 2004

NCT ID
NCT00092456

About rotavirus vaccine, live, oral, pentavalent + Placebo

rotavirus vaccine, live, oral, pentavalent + Placebo is a phase 3 stage product being developed by Merck for Rotavirus Infections. The current trial status is completed. This product is registered under clinical trial identifier NCT00092456. Target conditions include Rotavirus Infections.

What happened to similar drugs?

1 of 12 similar drugs in Rotavirus Infections were approved

Approved (1) Terminated (1) Active (10)
❌Rotavirus Vaccine, Live, Oral, Pentavalent + Comparator: Rotarix™ administered concomitantly with Tritanrix™ HepB (DTwP) + Comparator: RotaTeq™ administered concomitantly with INFANRIX™ (DTaP)MerckPhase 3
🔄RotaTeq™, rotavirus vaccine, live, oral, pentavalent + Comparator: Placebo matching RotaTeq™MerckPhase 3
🔄Rotavirus Vaccine, Live, Oral, Pentavalent + Comparator: Oral Poliovirus Vaccine (OPV) + Comparator: Oral Poliovirus Vaccine (OPV) (staggered)MerckPhase 3
🔄RotaTeq (V260) + IPVMerckPhase 3
🔄Rotateq™ + Comparator: PlaceboMerckPhase 3
✅RotaTeq™ (V260) + DTP-IPVMerckApproved
🔄Rotavirus Vaccine, Live, Oral, Pentavalent + Comparator: PlaceboMerckPhase 3

Hype Score Breakdown

Clinical
17
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT00092456Phase 3Completed

Competing Products

14 competing products in Rotavirus Infections

See all competitors
ProductCompanyStageHype Score
Rotavirus Vaccine, Live, Oral, Pentavalent + Comparator: Rotarix™ administered concomitantly with Tritanrix™ HepB (DTwP) + Comparator: RotaTeq™ administered concomitantly with INFANRIX™ (DTaP)MerckPhase 3
32
RotaTeq™, rotavirus vaccine, live, oral, pentavalent + Comparator: Placebo matching RotaTeq™MerckPhase 3
40
Rotavirus Vaccine, Live, Oral, Pentavalent + Comparator: Oral Poliovirus Vaccine (OPV) + Comparator: Oral Poliovirus Vaccine (OPV) (staggered)MerckPhase 3
40
RotaTeq (V260) + IPVMerckPhase 3
40
Rotateq™ + Comparator: PlaceboMerckPhase 3
40
RotaTeq™ (V260) + DTP-IPVMerckApproved
43
Comparator: RotaTeq + Comparator: Placebo + Comparator: RotaTeq + PlaceboMerckPhase 1
21
Rotavirus Vaccine, Live, Oral, Pentavalent + Comparator: PlaceboMerckPhase 3
40
V260 + Placebo to V260 + OPV + DTaPMerckPhase 3
40
Rotavirus Vaccine, Live, Oral, Pentavalent + Comparator: Placebo + Rotavirus Vaccine, Live, Oral, Pentavalent + Comparator: PlaceboMerckPhase 1
29
Rotavirus Vaccine, Live, Oral, Pentavalent + Comparator: placebo + Comparator: Infanrix(tm) HexaMerckPhase 3
40
RotaTeq™ experimental formulation + RotaTeq™ existing formulationMerckPhase 3
40
Rotarix + RotaTeqMerckPhase 3
40
Rotavirus Vaccine, Live, Oral, Pentavalent (V260, RotaTeq™) + Comparator: Comparator: Placebo (unspecified)MerckPhase 3
40